Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.350
-0.025 (-6.77%)
Nov 21, 2024, 1:04 PM EST - Market open
CYCC's stock price has decreased by -92.4% in the past year and price targets may not have had time to catch up.
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$11.00
Upside
+3,044.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +3,044.65% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $16 → $21 | Strong Buy | Maintains | $16 → $21 | +5,903.43% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $120 | Buy | Maintains | $120 | +34,205.32% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +34,205.32% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +72,798.80% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +72,798.80% | Apr 30, 2021 |